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Abstract
Background: The prevalence of overactive bladder syndrome (OAB) increases with age. Sleep disturbances in
elderly individuals with OAB is a common problem. The purpose of this study was to examine the effects of a
biofeedback-based sleep improvement (BBSI) program on urinary symptoms and sleep patterns in elderly Korean
women with OAB.
Methods: A non-equivalent control group pre−/post-test design was used. Elderly women with OAB were assigned
to an intervention group (n = 20) or a control group (n = 18). The BBSI program was implemented in the
intervention group for 12 weeks, while two educational sessions of general sleep hygiene and lifestyle modification
were provided to the control group. Using SPSS 23.0, the data were analyzed by descriptive analysis using the chi-
square test, Fisher’s exact test, Mann-Whitney test, and Wilcoxon test.
Results: After the 12-week BBSI program, significant improvements were found in the intervention group’s the
square root of the mean squared differences of successive R-R intervals (p = 0.025), low frequency/high frequency
ratio (p = 0.006), and epinephrine (p = 0.039). We also observed a significant difference in urinary symptoms, sleep
efficiency, wake after sleep onset, number of awakenings, and number of awakenings within 3 h after sleep onset
(p < 0.001, p = 0.004, p = 0.001, p = 0.001, and p = 0.048, respectively). However, no significant changes were found in
these variables in the control group.
Conclusions: The BBSI program effectively improved urinary symptoms and sleep patterns of elderly Korean
women with OAB. Further longitudinal research is required to investigate the sustainability and effects of the BBSI
program.
Trial registration: KCT0003882. Date of registration: 02/05/2019. Retrospectively registered.
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Background
Sleep disorders in elderly individuals with overactive
bladder syndrome (OAB) are a common problem. The
prevalence of OAB in elderly individuals in the United
States and Europe is 16.9 and 11.8%, respectively [1, 2].
OAB is characterized by major lower urinary tract dys-
function that causes urinary frequency, nocturia, and
urinary urgency irrespective of urge incontinence [3]. Its
prevalence increases with age [2] and lower physical
activity [4] and is higher in females than in males [1].
Nocturia is the most uncomfortable lower urinary tract
symptom in elderly individuals; it directly causes sleep
disturbances and increases the risk of falls and fractures
[5]. Frequent awakening due to symptoms of OAB dis-
turbs the quality of sleep, resulting in severe fatigue in
daytime activities [6].
The cause of OAB has not been identified yet; how-
ever, one or more physiological changes are thought to
play a role in its development [7]. OAB without the
presence of a neurological disease has been attributed to
autonomic nervous system (ANS) abnormalities based
on the role of the ANS in regulating bladder function
[8]. The parasympathetic nervous system induces blad-
der contractions, while the sympathetic nervous system
regulates the contractions of the bladder neck and ureth-
ral smooth muscle and relaxation of the bladder body
[9]. Therefore, ANS imbalances can result in abnormal
bladder activity [8].
Although elderly individuals can suffer from sleep dis-
orders secondary to OAB, aging itself causes ANS
changes, leading to increased and decreased activities of
the sympathetic and parasympathetic nervous systems,
respectively, thereby lowering the sleep quality [10]. Ex-
cessive sympathetic nervous system activity leads to
frequent awakening and interferes with deep sleep,
suggesting that sleep interventions in elderly women
should be directed towards maintaining balance in the
ANS [11, 12].
However, active efforts to solve such problems are
lacking because most patients tend to perceive this issue
as a natural phenomenon due to aging. Few studies have
examined the management of symptoms in the elderly
at the physiological level and few interventions are avail-
able to address sleep disorders. Sleep disorders are often
considered characteristic of elderly patients. Addition-
ally, there are limited drug therapies that can be used to
improve sleep problems in elderly people with OAB.
Anti-muscarinic drugs are the most commonly used
ones in the treatment of OAB; however, long-term
adherence to the management is very low due to the side
effects, such as constipation and dry mouth [13, 14]. Par-
ticularly, elderly patients may be on multiple drugs for
various comorbidities; therefore, care must be taken in
prescribing these drugs. For this reason, several studies
have suggested that multicomponent treatment should
be considered as the first-line therapy for OAB in elderly
people [15, 16].
In this study, we aimed to use mechanism-based inter-
ventions to improve sleep in elderly people with OAB
and focused on using mechanisms to balance the ANS.
A therapeutic approach towards balancing the ANS is
essential to be an effective sleep intervention in elderly
patients with OAB. The use of biofeedback from the
sympathetic and parasympathetic nervous systems to
balance the ANS appears to be an important approach
in alleviating the symptoms of OAB. Additionally, bio-
feedback has been reported to be not only an effective
intervention in patients with physical and psychological
disorders secondary to ANS imbalances but also a suit-
able sleep intervention as well [17].
In the literature, changes in autonomic functions
might be the underlying cause of OAB and lowered
sleep quality. OAB also could be one of the major fac-
tors that interfere with deep sleep in the elderly. There-
fore, we hypothesized that stabilizing the autonomic




This experimental study used a multi-site nonequivalent
control group pre- and post-test design.
Participants and procedures
This study was conducted between March and Septem-
ber 2018. Our study population was selected from the
elderly women registered in two senior welfare centers
in Korea. The inclusion criteria were the following: (1)
age ≥ 65 years; (2) Overactive Bladder Symptom Score
(OABSS) ≥ 3, and urgency score ≥ 2 [18]; (3) Pittsburgh
Sleep Quality Index (PSQI) score ≥ 5 [19]; (4) Mini-
Mental State Examination (MMSE) ≥ 24 [20]; and (5) no
history of participation in other programs to improve
sleep over the previous 6 months. Participants were ex-
cluded if they were consuming sleeping pills or OAB
medications, had a history of urinary tract infection at
the time of the survey, were diagnosed with neurological
or psychiatric disorders or autonomic neuropathy, or
were diagnosed with other diseases affecting autonomic
function.
To recruit the participants, we visited each senior wel-
fare center and obtained permission to explain the study
to prospective elderly participants. We then explained
the study’s purpose and procedures and invited inter-
ested elderly patients to participate. We also used post-
ers to invite elderly women to participate. After
consulting the chief of each center, using a coin toss,
one center was assigned to provide the experimental
Park et al. BMC Urology          (2019) 19:109 Page 2 of 10
group and the other the control group. The intervention
was initiated a week after the categorization. The flow-
chart of patient selection is depicted in Fig. 1. Of the 55
enrolled women, 9 women refused to participate in the
study; therefore, 23 were included in the biofeedback-
based sleep improvement (BBSI) program, while another
23 patients were only managed in terms of sleep hygiene
and lifestyle modifications. Overall, eight patients were
lost to follow-up and dropping out; the remaining 38
were followed up for 12 weeks (20 in the BBSI group vs.
18 in the control group).
For the pre-test, the participants arrived at the study lo-
cation and rested for more than 30min. Three research
assistants administered the questionnaire and measured
heart rate variability (HRV). For HRV measurements, the
participants were suggested to relax and instructed to
breathe comfortably without speaking. After the 12-week
intervention, a follow-up evaluation was conducted with
the same contents as those in the pre-test. The research
assistants examined the same items as in the pre-test to
minimize measurement errors.
Sample size estimation
The sample size of this study was determined using the
G power version 3.1.9 program. The sample size was cal-
culated based on a two-sided test with significance level
of 0.05, power of 0.80, and effect size of (d) 0.99 [21] in
the study of sleep disorders. As a result, there were a
total of 36 participants, 18 of whom were required in
each group to evaluate differences between the two
groups. Its actual power was 0.82. In the present study,
23 in the experimental group and 23 in the control
group were chosen as candidates for participation in the
program based on a dropout rate of 20%.
Intervention
The intervention program was developed to improve
sleep in elderly women with OAB. We designed the
Fig. 1 The CONSORT flow diagram. BBSI: Biofeedback based sleep improvement
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program with an emphasis on ANS balance, including
individual intervention, group education, and telephone
coaching. We prepared an intervention plan by review-
ing the literature based on Overactive Bladder Syndrome
Treatment Guidelines [22] and Sleep Hygiene Education
provided by the Korean Society of Sleep Medicine [23].
The components of the program consisted of direct and
indirect elements that have been previously reported to
be effective for autonomic balance. Biofeedback was used
for the direct approach for ANS balance [24], and lifestyle
modifications, physical activity, and depression manage-
ment—which were reported to be effective for ANS
balance—were used as indirect approaches [25–27]. Add-
itionally, behavioral therapy is very important in sleep
disorders with OAB. Therefore, the participants were edu-
cated regarding sleep hygiene in consideration of OAB
characteristics and pelvic floor muscle (PFM) contraction
exercises were included in the program [28, 29]. The main
outlines of the BBSI program were as follows: (1) individ-
ual intervention: HRV biofeedback training—a key com-
ponent of ANS balance; (2) group training: behavioral
therapy to reduce OAB symptoms and improve sleep,
including lifestyle modifications, sleep hygiene, pelvic
muscle contractions, physical activity, and depression
management; and (3) telephone coaching: emotional sup-
port and individual goal setting. An additional file shows
this in more detail [see Additional file 1].
The individual interventions consisted of weekly bio-
feedback training for 20min for 12 weeks. For biofeedback
training, a computerized biofeedback system (Procomp,
Thought Technology, Montreal, QC, Canada) was used.
By analyzing the changes in the visual heart rhythm and
respiration, HRV biofeedback balances the ANS by con-
trolling the respiratory rate. The intervention provider was
an experienced urology nurse who was well-trained to
provide biofeedback. Biofeedback confirmed the partici-
pant’s baseline status in pre-testing and maintained an
ideal state (close to 1.5) of low frequency (LF) to high fre-
quency (HF) ratio (LF/HF) during training [30].
Group education was conducted for 40 min once a
week for 12 weeks. It consisted of sleep hygiene educa-
tion, lifestyle modifications, PFM contraction exercises,
physical activity, and depression management. The life-
style modification program included body mass index
control, caffeine restriction, and alcohol restriction. A
pedometer was provided to increase each participant’s
amount of physical activity. After each round of group
training, individual counseling was provided to encour-
age each participant to achieve their goals.
Telephone coaching was conducted to encourage goal
achievement and provide emotional support. We en-
couraged the use of biofeedback-based respiration tech-
niques every day and set individual and daily goals to
promote physical activity. We then confirmed that they
practiced the same. Emotional support was provided
after identifying the participants’ environmental and psy-
chological statuses. Also, for positive reinforcement, the
program provided participants with a workbook at the
beginning of the program and rewarded participants
who achieved the goal well during the mid-term check.
The control group received 40min of training on sleep
hygiene and lifestyle modifications in the 4th and 8th
sessions of intervention, respectively. In order to main-
tain consistency in the contents of the two groups, edu-
cation was conducted by the same educators in both
groups. Additionally, before the program began, the re-
searchers agreed on the materials to be provided to both
groups and conducted the training in accordance with
the agreed content. Sleep hygiene education consisted of
the same 11 sleep hygiene items as those of the interven-
tion group. Regarding lifestyle modifications, the control
group was instructed to restrict caffeine and water




HRV was used to assess the sympathetic and parasympa-
thetic activities since it enables qualitative, quantitative,
and noninvasive analysis of global autonomic function
[17, 31]. To assess ANS activity, HRV was measured
with a heart rate monitoring device (Polar V800, Polar
Electro Oy, Kempele, Finland). All R-R intervals col-
lected through the wireless chest strap of the heart rate
monitor were recorded with a 1000-Hz wireless heart
rate monitor suitable for HRV analyses. After the meas-
urement, the raw data were extracted by the Pro-trainer
Polar 5 (version 5.40.171, Polar Electro) program and
transferred to Kubios (version 2.0, 2008, Biosignal
Analysis and Medical Imaging Group, Finland). We eval-
uated HRV with the converted values in Kubios.
The results of HRV demonstrate the values in time
and frequency domains for ANS activity. The parameters
of the time domain analysis were the standard deviation
of Normal to Normal R-R intervals (SDNN) and the
square root of the mean squared differences of succes-
sive R-R intervals (RMSSD). SDNN estimates the overall
HRV, while RMSSD represents parasympathetic activity.
The parameters of the frequency domain analysis were
total power (TP), LF, HF, and LF/HF ratio. TP reflects
the control capacity of the ANS, LF (0.04–0.15 Hz)
represents sympathetic activity, and HF (0.15–0.4 Hz)
represents the parasympathetic activity. The LF/HF ratio
represents the interaction and balance between the two
systems [32].
With the participants breathing normally, we calcu-
lated SDNN, RMSSD, TP, LF, HR, and LF/HF ratio. The
participants were instructed not to smoke or drink
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alcohol or caffeinated beverages after 10 pm on the night
before data collection. Each participant was seated on a
comfortable chair and the HRV monitor was placed on
the left wrist. Participants were asked not to talk and
breathe at a normal rate during the 5-min measurement.
Plasma catecholamine level
Epinephrine (epi) and norepinephrine were assayed
using blood samples. Each participant was instructed to
lie quietly for 30 min before the blood sampling. Venous
blood (5 mL) was obtained in a heparin anticoagulation
vacuum tube. Catecholamine levels were measured by
high-performance liquid chromatography (Acclaim, Bio-
Rad, United States of America).
OAB symptoms
OAB symptom severity was measured using 8 of the 33
items of the Overactive Bladder Questionnaire (OAB-q)
developed by Cyone et al. [33]. The 8-item questionnaire
consisted of 4 sub-areas: frequency, urgency, nocturia,
and urge incontinence. Each item consists of a 6-point
Likert scale ranging from “not affected at all” (1 point)
to “strongly affected” (6 points). The symptom severity
scale was calculated by the converted scores given by
Coyne et al. [33] using a range of 0–100. The higher the
score, the greater the severity of OAB symptoms. Cron-
bach’s α was 0.86 [33] vs. Cronbach’s α of 0.79 in our
study.
Sleep patterns
We measured sleep efficiency (SE), wake after sleep on-
set (WASO), number of awakenings, and number of
awakenings within 3 h of sleep onset using actigraphy
(W-GT3X-BT, Actigraph, Inc., Pensacola FL, United
States of America) to assess sleep. The actigraphy device
can be worn on the waist or wrist using an elastic belt.
In elderly individuals, wearing an actigraphy device on
the wrist reportedly reduces the sensitivity of low-
intensity activities when using walking aids [34, 35];
therefore, we chose to place it on the waist. The data
collected by the actigraphy device was analyzed by Acti-
life 6 software to obtain SE, WASO, number of awaken-
ings, and number of awakenings within 3 h of sleep
onset. In this study, sleep was scored using medium
threshold settings and default parameters for sleep scor-
ing based on 1-min epochs. Since the measurement
period of the actigraphy is at least 3 consecutive days
[36], the participants wore the actigraphy device during
sleep for 3 days. We also asked the participants to ac-
curately collect information regarding bedtime and
rise time for each night while they were wearing the
actigraphy device.
Data analysis
The data were analyzed using SPSS for Windows version
20.0 (SPSS Inc., Armonk, NY, United States of America).
We used the Chi-square test, Fisher’s exact test, and
Mann–Whitney test to test the homogeneity of the gen-
eral characteristics of the experimental and control
groups. The efficacy of the BBSI program was analyzed
using the Wilcoxon test. Cronbach’s test was used to
confirm reliability. P values < 0.05 were considered to be
statistically significant.
Results
Twenty elderly women with OAB treated with the BBSI
program (BBSI group) and 18 with OAB without the BBSI
program (control group) were included in the present
study. The patients’ basic characteristics, clinical and la-
boratory parameters of ANS activity, OAB symptoms, and
sleep patterns are summarized in Table 1. The mean age in
the BBSI group and control group was 80.05 ± 4.21 and
81.06 ± 4.32 years, respectively. There were no intergroup
differences in the educational level, marital status, monthly
income, parity, caffeine intake, water intake, BMI, or OAB
duration. Regarding the parameters of HRV, catechol-
amines, OAB symptoms, and sleep patterns did not differ
between the groups.
The effects of the 12-week BBSI program on the HRV
parameters and plasma catecholamine levels are summa-
rized in Table 2. Significant decreases were observed in
RMSSD (37.02 ± 35.56 vs. 51.93 ± 49.61, p = 0.025), LF/
HF ratio (2.59 ± 2.23 vs. 1.03 ± 0.27, p = 0.006), and epi-
nephrine levels (42.31 ± 13.58 vs. 34.69 ± 12.83, p =
0.039) in the BBSI group after the intervention, whereas
SDNN, TP, LF, and HF did not differ after the interven-
tion. All the parameters related to HRV and plasma cat-
echolamine levels in the control group did not change in
the control group after the 12-week period.
The effects of the 12-week BBSI intervention on OAB
symptoms measured by OAQ-q are summarized in Table 3.
At baseline, no significant difference was found in the fre-
quency, urgency, nocturia, or urgency incontinence between
the patients and controls (Table 1). After the 12-week inter-
vention, the BBSI group demonstrated a significant im-
provement in the urgency score (8.5 ± 1.5 vs. 7.5 ± 0.82, p=
0.004), nocturia (9.35 ± 2.08 vs. 6.85 ± 1.42, p < 0.001), and
total score (48.81 ± 10.59 vs. 33.96 ± 7.31, p < 0.001).
Table 4 shows that, regarding sleep patterns, in the
BBSI group, we observed a significant difference in SE,
WASO, number of awakenings, and number of awaken-
ings within three hours after sleep onset (p = 0.004, p =
0.001, p = 0.001, and p = 0.048, respectively).
Discussion
In this study, we aimed to develop, apply, and analyze
the efficacy of a BBSI program in elderly women with
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OAB who were assumed to have an overall ANS imbal-
ance due to excessive sympathetic activity. The program
included biofeedback training using HRV, lifestyle modi-
fications, physical activity, depression management, sleep
hygiene, and PFM exercises. After the 12-week program,
RMSSD—a key indicator of HRV—had increased signifi-
cantly, while the LF/HF ratio and epinephrine secretion
decreased significantly. Furthermore, OAB symptoms
had alleviated. These results improved sleep by decreas-
ing WASO, number of awakenings during sleep, number
of awakenings within 3 h of sleep onset, and increasing
sleep efficiency (SE).
Notable results of this study were that post-
intervention RMSSD in the experimental group in-
creased significantly, whereas the post-intervention LF/
HF ratio decreased significantly. No differences were ob-
served in these indicators in the control group after
completion of the study. Biofeedback using HRV effect-
ively treated the psychological issues, such as depression,
panic, and insomnia through ANS balance [17]. The
Table 1 Homogeneity test for general characteristics and baseline of variables (N = 38)
Variables BBSI (n = 20) Control (n = 18) p
Mean ± SD or n (%)
Age (yr) 80.05 ± 4.21 81.06 ± 4.32 .472
Education level <Elementary school 17 (80.0) 15 (83.4) .383
≥ Middle school 3 (15.0) 3 (16.6)
Spouse Yes 3 (15.0) 3 (16.7) .616†
No 17 (85.0) 15 (83.3)
Monthly income < 100 20 (100.0) 17 (95.0) .474†
(10,000 won) ≥ 100 0 (0.0) 1 (5.0)
Parity (number) 3.80 ± 1.58 3.17 ± 1.92 .272
Caffeine intake (cup/day) < 4 10 (50.0) 11 (61.1) .492
≥ 4 10 (50.0) 7 (38.9)
Water intake (cc/day) < 1000 12 (60.0) 15 (83.3) .113†
≥ 1000 8 (40.0) 3 (16.7)
Regular exercise (/week) < 3 17 (85.0) 15 (83.3) .263†
≥ 3 3 (15.0) 3 (16.7)
BMI (kg/m2) 23.95 ± 3.96 24.13 ± 2.94 .882
OAB duration (yr) 2.35 ± 2.38 1.58 ± 1.29 .225§
HRV
SDNN (ms) 29.79 ± 29.13 25.54 ± 19.48 .826§
RMSSD (ms) 37.02 ± 35.56 28.97 ± 23.93 .682§
TP (ms2) 2893.95 ± 6692.99 1303.61 ± 3158.63 .748§
LF (ms2) 1429.35 ± 3794.62 735.39 ± 1657.95 .815§
HF (ms2) 856.20 ± 1579.64 638.89 ± 1562.95 501§
LF/HF ratio 2.59 ± 2.23 2.81 ± 2.13 .520§
Catecholamines
E (pg/mL) 42.31 ± 13.58 50.56 ± 18.73 .126§
NE (pg/mL) 472.84 ± 198.28 511.77 ± 195.55 .520§
OAB symptom severity 42.81 ± 10.59 38.54 ± 11.83 .248§
Sleep
SE (%) 86.89 ± 4.93 87.77 ± 5.39 .619§
WASO (min) 69.20 ± 27.57 56.27 ± 22.94 .128§
Number of awakenings 10.85 ± 4.16 10.14 ± 4.80 .609§
Number of awakenings in 3 h after sleep onset 4.48 ± 1.74 4.09 ± 1.81 .702§
†Fisher’s exact test; § Mann-Whitney test; BBSI Biofeedback-based sleep improvement program, OAB Overactive bladder syndrome, SDNN Standard deviation of all
normal to normal R-R intervals, RMSSD Root mean square differences of successive R-R intervals, TP Total power, LF Low frequency, HF High frequency, Epi
Epinephrine, NE Norepinephrine, SE Sleep efficiency, WASO Wake after sleep onset
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ANS also demonstrated other benefits, such as decreased
pulse, increased body temperature, and improved blood
circulation [37].
According to previous studies in females with OAB,
the LF/HF ratio is significantly increased when the blad-
der is full [38, 39]. Hsiao et al. emphasized that the sym-
pathetic nervous system is relatively overactive in OAB
because the LF/HF ratio is higher in women with OAB
than that in healthy adults, even when the bladder is
empty [40]. Similarly, Choi et al. [41] reported that HF—
a frequency domain indicator of RMSSD and parasym-
pathetic nerve activity—was decreased in women with
OAB compared to healthy adults. RMSSD increased and
LF/HF ratio decreased after the intervention in this
study—a finding that was consistent with ANS changes
that may help alleviate OAB symptoms. Furthermore,
Hubeaux et al. suggested that ANS dysfunction due to
sympathetic predominance may be implied in the gener-
ation of abnormal bladder sensations, such as urgency
[38, 39]. In contrast, increased parasympathetic nerve
activity has been reported as a cause of OAB [7, 42] or
nocturia [43]. There are differences in the participants
and data collection methods in these studies; therefore,
direct comparison is difficult. However, our biofeedback
protocol was designed to activate the parasympathetic
nerves while keeping the LF/HF ratio at an appropriate
value during biofeedback training, which may have been
an important factor in alleviating OAB symptoms. Con-
sidering the results of previous studies, the results of this
study confirm the possibility of ANS imbalance due to
sympathetic dominance as the cause of OAB. ANS
changes associated with senescence involve increase and
decrease in the activities of the sympathetic and para-
sympathetic nervous systems, respectively [10, 44]. Such
changes lead to sleep disturbances, including frequent
awakening and reduced rapid eye movement (REM)
sleep [44]. In one study, RMSSD was reported to be
lower in elderly individuals than that in younger individ-
uals, and this finding was more common in females [45].
Therefore, increased RMSSD may induce deep sleep and
stabilize sleep structure. Further, serum epinephrine was
significantly reduced after 12 weeks in the BBSI group.
The LF/HF ratio is well-known to better reflect sympa-
thetic nervous system balance than any other single indi-
cator [30], whereas the circulating epinephrine level is
directly related to sympathetic activity. Therefore, serum
epinephrine level is a powerful tool for evaluating the
program efficacy.
Table 2 Effects of the BBSI program on the levels of heart rate variability parameters and catecholamines (N = 38)
Variables BBSI (n = 20) Control (n = 18)
Pre Post Pre Post
Mean ± SD Mean ± SD p Mean ± SD Mean ± SD p*
SDNN (ms) 29.79 ± 29.13 47.47 ± 37.51 .113 25.54 ± 19.48 21.63 ± 11.50 .420
RMSSD (ms) 37.02 ± 35.56 51.93 ± 49.61 .025 28.97 ± 23.93 29.39 ± 22.45 .758
TP (ms2) 2893.95 ± 6692.99 2036.60 ± 4422.05 .550 1303.61 ± 3158.63 2302.22 ± 5030.27 .983
LF (ms2) 1429.35 ± 3794.62 804.85 ± 2132.54 .455 735.39 ± 1657.95 1074.83 ± 2463.03 .433
HF (ms2) 856.20 ± 1579.64 1147.25 ± 2163.45 .709 638.89 ± 1562.95 844.33 ± 1893.83 .647
LF/HF ratio 2.59 ± 2.23 1.03 ± 0.27 .006 2.81 ± 2.13 2.42 ± 1.30 .446
Epi (pg/mL) 42.31 ± 13.58 34.69 ± 12.83 .039 50.56 ± 18.73 59.20 ± 23.59 .076
NE (pg/mL) 472.84 ± 198.28 434.91 ± 180.38 .218 511.77 ± 195.55 457.87 ± 210.90 .129
BBSI Biofeedback-based sleep improvement program, OAB Overactive bladder syndrome; p: difference from pre-test to post-test in BBSI groups p*: difference from
pre-test to post-test in control groups, SDNN Standard deviation of normal to normal R-R intervals, RMSSD Root mean square differences of successive R-R
intervals, TP Total power, LF Low frequency, HF High frequency, E Epinephrine, NE Norepinephrine
Table 3 Effects of BBSI program on the severity of OAB symptoms, as measured by OAB-q (N = 38)
Variables BBSI (n = 20) Control (n = 18)
Pre Post Pre Post
Mean ± SD Mean ± SD p Mean ± SD Mean ± SD p *
Frequency 2.00 ± 0.79 1.95 ± 0.51 .782 2.22 ± 0.73 1.94 ± 0.54 .132
Urgency 8.50 ± 1.50 7.50 ± 0.82 .004 7.50 ± 1.00 7.39 ± 1.58 .756
Nocturia 9.35 ± 2.08 6.85 ± 1.42 <.001 8.44 ± 2.06 8.39 ± 1.29 .979
Urgency incontinence 6.70 ± 2.11 6.00 ± 1.84 .100 6.33 ± 3.12 5.33 ± 2.33 .055
Total 42.81 ± 10.59 33.96 ± 7.31 <.001 38.54 ± 11.83 35.53 ± 9.44 .214
BBSI Biofeedback-based sleep improvement program, OAB Overactive bladder syndrome, OAB-q Overactive bladder questionnaire; p: difference from pre-test to
post-test in BBSI groups; p*: difference from pre-test to post-test in control groups
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Urinary symptom severity was significantly decreased
in the experimental group, while no differences were
noted in the control group. Symptoms of OAB are dir-
ectly affected by changes in sleep structure due to aging,
such as decreased REM and slow wave sleep [5]. Active
interventions for these direct factors play an important
role in improving sleep in elderly individuals [46]. The
primary intervention for alleviating urinary symptoms is
behavioral therapy, especially in elderly patients. This
treatment is safer and has fewer side effects than drug
therapy or surgery [47, 48] and has better subjective
assessment of symptoms than drug therapy [49].
Few previous studies have focused on ANS as a medi-
ator in the relief of OAB symptoms. Cho et al. [50]
attempted to alleviate OAB symptoms by inducing ANS
changes using Tai-chi. No change in ANS activity was
observed but urinary symptoms were alleviated without
improvement in nocturia [50]. However, in the present
study, nocturia and urgency were improved—but not
frequency and urgency incontinence. We believe that
this difference in the outcome was due to the focus of
the intervention. In OAB patients—especially those with
urgency incontinence—it is important to acquire skills
to respond to urgency situations, such as PFM contrac-
tion and relaxation techniques [48]. However, the inter-
vention program of this study was composed mainly of
factors that reduce nocturia by emphasizing the practice
of sleep hygiene—including water and caffeine restric-
tion—urination before bedtime, and performing appropri-
ate exercise to reduce awakening. These results indicate
that urinary symptoms are related to several factors and
that a customized intervention for each symptom is neces-
sary for symptomatic relief [47].
In this study, SE increased, while wakefulness after
sleep onset, number of awakenings during sleep, and
number of awakenings within 3 h after sleep onset de-
creased, and overall sleep improved in the experimental
group after the program. In elderly women with OAB,
SE reduced and WASO increased significantly due to
decreased urinary symptoms and exacerbated changes
that occur during the normal aging process [5, 51]. Fur-
thermore, since sympathetic nervous activity may affect
REM sleep and induce nocturia [52], these results sug-
gest that increasing RMSSD and decreasing the LF/HF
ratio improves sleep in elderly women with OAB. Par-
ticularly, lower sleep quality due to nocturia is a problem
due to which patients with OAB are the most inconve-
nienced [53]. Decreased wakefulness after sleep onset is
associated with reduced nocturnal enuresis. Additionally,
the frequency of awakening due to urination in the ini-
tial stages of sleep is a key parameter for clinically asses-
sing the quality of sleep and life [54]. The frequency of
awakening during sleep is known to increase with age
and this frequency is important in terms of sleep quality
in elderly individuals with OAB because it can be diffi-
cult to return to sleep after awakening [55]. The elderly
demonstrate slow sleep—which is deep sleep for 3 h after
sleep onset—during which arousal has the greatest effect
on daytime drowsiness and disruption of daily activities
[56]. The decrease in awakening frequency seems to posi-
tively affect sleep quality by increasing sleep continuity.
This study introduced a method to effectively treat
sleep disorders using a program that addresses the
physiological issues to alter ANS imbalances. A strong
point of the program is that it addresses the issue inte-
grally by approaching sleep disruption in view of the
characteristics of OAB. Additionally, as an early study of
sleep problems in patients with OAB, considerable re-
sults were obtained that confirm that ANS stabilization
is effective in improving OAB and sleep. Based on the
results of this study, it also may be possible to apply
ANS stabilization to OAB patients more easily in daily
life, such as relaxation and meditation therapy [57].
Despite the strengths, the study has some limitations.
First, the study has the potential for bias due to the use
of a non-randomized controlled trial design and no
blinding between the researchers and participants. Sec-
ond, HRV measurements—reflecting ANS—were evalu-
ated during daytime stability and do not reflect changes
in sleep and bladder activity at other times of the day.
Third, the findings should be generalized with caution as
there is the possibility of interference from external vari-
ables and the fact that only two senior welfare centers in
Korea were included. Finally, it is difficult for the
Table 4 Effects of the BBSI program on the patterns of sleep parameters (N = 38)
Variables BBSI (n = 20) Control (n = 18)
Pre Post Pre Post
Mean ± SD Mean ± SD p Mean ± SD Mean ± SD p *
SE (%) 86.89 ± 4.93 90.54 ± 4.36 .004 87.77 ± 5.39 86.71 ± 6.07 .717
WASO (min) 69.20 ± 27.57 37.28 ± 21.16 .001 56.27 ± 22.94 59.48 ± 22.87 .281
Number of awakenings 10.85 ± 4.16 7.12 ± 2.89 .001 10.14 ± 4.80 10.94 ± 4.21 .236
Number of awakenings
in 3 h after sleep onset
4.48 ± 1.74 3.44 ± 1.74 .048 4.09 ± 1.81 4.65 ± 2.29 .256
BBSI Biofeedback-based sleep improvement program, OAB Overactive bladder syndrome; p: difference from pre-test to post-test in BBSI groups; p*: difference from
pre-test to post-test in control groups; SE Sleep efficiency, WASO Wake after sleep onset
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participants to apply the BBSI program’s protocol to
their daily life on their own. Further studies with larger
samples with randomized control trial designs and direct
ANS activity measurements are needed to evaluate the
precise relationships between ANS activity, bladder ac-
tivity, and sleep patterns. Additionally, simplifying the el-
ements of the program and making it easier to apply in
everyday life will help the participants manage the disor-
ders on their own.
Conclusions
This study tested a BBSI program in elderly women with
OAB in a coordinated manner and demonstrated that
the program could improve ANS balance, alleviate urin-
ary symptoms, and improve sleep. The results of this
intervention study demonstrate that it is meaningful to
consider physiological factors in sleep interventions.
Therefore, the program is expected to positively affect
the quality of sleep and life in elderly women with OAB.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12894-019-0540-y.
Additional file 1. Biofeedback-based sleep improvement program
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